share_log

Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...

Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...

Hims与Hers健康股份的成交量增加;交易员传阅关于Lilly的Tirzepatide供应短缺的法庭文件,各方同意遵照2024年10月法院的命令维持停留,联合状态报告需于2024年12月19日前提交,或...
Benzinga ·  11/21 16:10

Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or Within Seven Days Of FDA's New Decision

Hims与Hers健康股票成交量大,交易者传阅法庭文件,涉及Lilly的Tirzepatide短缺,各方同意按2024年10月法庭命令维持停留,联合状态报告需在2024年12月19日前提交,或在FDA做出新决定后的七天内提交。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发